San Jose, CA (PRWEB) August 24, 2011
Joint health has taken an increasingly prominent place in the pharmaceutical industry in recent years. With the decline in mortality rate globally resulting in increased longevity of life, medicines or dietary supplements catering to the needs of elderly population have gained increased attention. Glucosamine forms one of the supplements of choice for the elderly and sports individuals, backed by its ability to rebuild damaged joint structures. The popularity of the ingredient is highlighted by the fact that Glucosamine forms part of more than 50% of the joint health supplements. Dietary supplements with Glucosamine help in maintaining joint casings, cartilage, joint fluid, and tendons. Glucosamine supplements also renew synovial fluid, and help in treating sports injuries. The product is often combined with Chondroitin to provide cartilage elasticity. Supplements with Glucosamine would reduce the progression of Osteoarthritis by more than 50%. Glucosamine presently dominates the joint health market as the best-selling dietary supplement.
Glucosamine market, over the past decade, exhibited steady and healthy growth worldwide, driven by the growing aging population, and promotions by companies regarding the health benefits of Glucosamine as a vital dietary supplement for joint health. Rising incidence of osteoarthritis is also expected to fuel market growth. The joint health benefits of Glucosamine facilitate in expanding the consumer base beyond the aging population, to include athletes and common individuals affected from arthritis-like ailments.
Japan represents the largest market for Glucosamine globally, as stated by the new market research report on Glucosamine. North America and Europe constitute the other major markets globally. Glucosamine in Europe has been approved for sale as a pharmaceutical drug, and is widely sold in the form of Glucosamine sulfate. Meanwhile, the US remains one of the major markets for Glucosamine supplements, with average per capita expenditure of about $2.7. China, on the other hand, remains the largest glucosamine producer and supplier worldwide, accounting for a lion’s share of the global glucosamine supply.
Recent trends exhibit the increasing popularity of Vegetarian Glucosamine. Available at a premium compared to the shellfish-derived material, Vegetarian glucosamine is mainly targeted at individuals allergic to shellfish, and to a specific section of population who strictly follow Jewish food habits. Major companies operating in the Vegetarian-source glucosamine include Cargill (Regenasure), Cyanotech (JointAstin), DNP International, EthicalNaturals, and Hygieia Health. Another significant trend observed in recent times is the promotions by manufacturers of the "Generally Recognized As Safe (GRAS)" status of glucosamine products. The market is also witnessing a growing interest in fortifying products, such as sport drinks and soft drinks, with Glucosamine owing to its joint health benefits. Global launches of new products fortified with Glucosamine increased from 95 in 2008 to more than 120 in 2009.
Major players of Glucosamine profiled in the report include Alcan Chemical Division, Alfa Chem, Cargill Inc., Dalian Lijian Bio-Technology Development Co. Ltd., Dalian Xindie Chitin Co. Ltd., Dee Pharmaceuticals Ltd., Ethical Naturals Inc., FabriChem Inc., Golden-Shell Biochemical Co. Ltd., Koyo Chemical Company Limited, Navamedic ASA, Nutraceutix Inc., Nutramax Laboratories Inc., Nutrilite, Promax Nutrition Corp., Schiff Nutrition International Inc., Shandong DongYing Development Zone Marine Biochemical Co., Ltd., Shandong Jinan Haidebei Marine Bioengineering Co. Ltd., Simply Supplements, Synasia Inc., Taizhou Candorly Sea Biochemical & Health Products Co., Ltd., Triarco Industries Inc., Xiamen Blue Bay Science & Technology Co. Ltd., Zhejiang Freeman Shinfuda Co. Ltd., among others.
The research report titled “Glucosamine: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the Glucosamine market, current market trends, key growth drivers, new research findings on Glucosamine, new product introductions and launches, recent corporate initiatives, and profiles of major/niche global as well as regional market participants. The report provides annual sales estimates and projections for Glucosamine for the years 2009 through 2017 for the following geographic markets - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. The study also presents historic data for the period 2003 through 2008.
For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Glucosamine_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/